Biotech Stock On The Radar: Evoke Pharma Sets Date With FDA

Biotech Stock On The Radar: Evoke Pharma Sets Date With FDA

In early March, the stock hit a long-term support around the $2.35 level and subsequently fell sharply, finding support around 50-60 cents. After wallowing in penny stock territory until mid-July, the …